Sangamo Therapeutics, Inc.
SGMO
$0.485
$0.00190.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.78% | 62.01% | 45.96% | -25.78% | -157.97% |
| Total Depreciation and Amortization | -54.23% | -57.82% | -58.43% | -30.63% | -9.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.87% | -91.11% | -89.25% | -48.51% | 29.52% |
| Change in Net Operating Assets | 204.72% | 103.60% | 95.26% | 96.45% | 94.04% |
| Cash from Operations | 78.46% | 70.14% | 50.58% | 27.05% | 10.28% |
| Capital Expenditure | 97.56% | 98.74% | 89.27% | 80.40% | 60.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -79.48% | -58.67% | -13.62% | 36.21% |
| Cash from Investing | -98.90% | -75.56% | -53.35% | 3.68% | 64.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -40.34% | 85.37% | -35.95% | -71.38% | -69.26% |
| Repurchase of Common Stock | -326.68% | 6.54% | 23.22% | 31.33% | 52.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.88% | 94.52% | -36.53% | -72.19% | -69.53% |
| Foreign Exchange rate Adjustments | -122.65% | -238.10% | 71.49% | -107.84% | -68.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.39% | 94.05% | 54.51% | 20.31% | 41.91% |